JB Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
JB Capital's PFE Position: Q2 2026 in Review
JB Capital increased its Pfizer (PFE) stake by 0.78% in Q2 2026, buying an estimated $9.78K and bringing the position to 48,121 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #135.
JB Capital first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.42M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- JB Capital held 48,121 shares of Pfizer worth $1.16M as of Q2 2026.
- JB Capital bought 374 Pfizer shares in Q2 2026, an estimated $9.78K.
- Pfizer made up 0.04% of JB Capital's portfolio in Q2 2026, its #135 holding.
- JB Capital first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
- JB Capital's Pfizer position peaked at $8.42M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.